Improvement of the noradrenergic symptom cluster following treatment with milnacipran

References

• CharneyDSMonoamine dysfunction and the pathophysiology and treatment of depressionJ Clin Psychiatry199859Suppl 141114
   Google Scholar
• LeonardBENoradrenaline in basic models of depressionEur Neuropsychopharmacol19977Suppl 1S11S169169306
   PubMed Web of Science ®Google Scholar
• BymasterFPMcNamaraRKTranPVNew approaches to developing antidepressants by enhancing monoaminergic neurotransmissionExpert Opin Investig Drugs200312531543
   PubMed Web of Science ®Google Scholar
• KlimekVSchenckJEHanHStockmeierCAOrdwayGADopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem studyBiol Psychiatry20025274074812372665
   PubMed Web of Science ®Google Scholar
• NuttDJRelationship of neurotransmitters to the symptoms of major depressive disorderJ Clin Psychiatry200869Suppl E14718494537
   PubMed Web of Science ®Google Scholar
• KasperSPailGMilnacipran: a unique antidepressantNeuropsychiatr Dis Treat20106233120856597
   PubMed Web of Science ®Google Scholar
• CarlssonACorrodiHFuxeKHökfeltTEffect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramineEur J Pharmacol196953573665786359
   PubMed Web of Science ®Google Scholar
• HealyDMcMonagleTThe enhancement of social functioning as a therapeutic principle in the management of depressionJ Psychopharmacol199711Suppl 4S25S319438230
   PubMed Web of Science ®Google Scholar
• KatonWThe impact of depression on workplace functioning and disability costsAm J Manag Care200915Suppl 11S322S32720088628
   PubMedGoogle Scholar
• WeissmanMMKlermanGLPaykelESTreatment effects on the social adjustment of depressed patientsArch Gen Psychiatry1974307717784832185
   PubMed Web of Science ®Google Scholar
• PaykelESWeissmanMMPrusoffBASocial maladjustment and severity of depressionCompr Psychiatry197819121128630854
   PubMed Web of Science ®Google Scholar
• HaysRDWellsKBSherbourneCDFunctioning and well-being outcomes of patients with depression compared with chronic general medical illnessesArch Gen Psychiatry19955211197811158
   PubMed Web of Science ®Google Scholar
• LeaderJBKleinDNSocial adjustment in dysthymia, double depression and episodic major depressionJ Affect Disord199637911018731071
   PubMed Web of Science ®Google Scholar
• TseWSBondAJThe impact of depression on social skillsJ Nerv Ment Dis200419226026815060399
   PubMed Web of Science ®Google Scholar
• BechPSocial functioning: should it become an endpoint in trials of antidepressantsCNS Drugs20051931332415813645
   PubMed Web of Science ®Google Scholar
• DalyEJTrivediMHWisniewskiSRHealth-related quality of life in depression: a STAR*D reportAnn Clin Psychiatry201022435520196982
   PubMed Web of Science ®Google Scholar
• WeissmanMMOlfsonMGameroffMJA comparison of three scales for assessing social functioning in primary careAm J Psychiatry200115846046611229989
   PubMed Web of Science ®Google Scholar
• BoscMDubiniAPolinVDevelopment and validation of a social functioning scale, the Social Adaptation Self-evaluation ScaleEur Neuropsychopharmacol19977Suppl 1S57S709169311
   PubMed Web of Science ®Google Scholar
• BoscMAssessment of social functioning in depressionCompr Psychiatry200041636910646621
   PubMed Web of Science ®Google Scholar
• HealyDReboxetine: its effects as measured by the Social Adaptation Self-evaluation ScaleActa Psychiatr Scand2000402Suppl4551
   Web of Science ®Google Scholar
• WareJEJrSherbourneCDThe MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selectionMed Care1992304734831593914
   PubMed Web of Science ®Google Scholar
• TseWSBondAJDifference in serotonergic and noradrenergic regulation of human social behavioursPsychopharmacology (Berl)200215921622111862352
   PubMed Web of Science ®Google Scholar
• WeissmanMMBothwellSAssessment of social adjustment by patient self-reportArch Gen Psychiatry19763311111115962494
   PubMed Web of Science ®Google Scholar
• TseWSBondAJReboxetine promotes social bonding in healthy volunteersJ Psychopharmacol20031718919512870566
   PubMed Web of Science ®Google Scholar
• TseWSBondAJNoradrenaline might enhance assertive human social behaviours: an investigation in a flatmate relationshipPharmacopsychiatry20063917517916944408
   PubMed Web of Science ®Google Scholar
• PaykelESWeissmanMMSocial adjustment and depression. A longitudinal studyArch Gen Psychiatry1973286596634700679
   PubMed Web of Science ®Google Scholar
• DubiniABoscMPolinVDo noradrenaline and serotonin differentially affect social motivation and behaviour?Eur Neuropsychopharmacol19977Suppl 1S49S559169310
   PubMed Web of Science ®Google Scholar
• DubiniABoscMPolinVNoradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioningJ Psychopharmacol199711Suppl 4S17S239438229
   PubMed Web of Science ®Google Scholar
• MassanaJMöllerHJBurrowsGDMontenegroRMReboxetine: a double-blind comparison with fluoxetine in major depressive disorderInt Clin Psychopharmacol199914738010220121
   PubMed Web of Science ®Google Scholar
• KellerMRole of serotonin and noradrenaline in social dysfunction: a review of data on reboxetine and the Social Adaptation Self-evaluation Scale (SASS)Gen Hosp Psychiatry200123151911226552
   PubMed Web of Science ®Google Scholar
• GorensteinCAndradeLMorenoRAArtesRSocial adjustment in depressed patients treated with venlafaxine and amitriptylineInt Clin Psychopharmacol20021717117512131600
   PubMed Web of Science ®Google Scholar
• MbayaPSafety and efficacy of high dose of venlafaxine XL in treatment resistant major depressionHum Psychopharmacol20021733533912415551
   PubMed Web of Science ®Google Scholar
• PjrekEWilleitMPraschak-RiederNTreatment of seasonal affective disorder with duloxetine: an open-label studyPharmacopsychiatry20084110010518484551
   PubMed Web of Science ®Google Scholar
• KochSHemrick-LueckeSKThompsonLKComparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in ratsNeuropharmacology20034593594414573386
   PubMed Web of Science ®Google Scholar
• StahlSMGradyMMMoretCBrileyMSNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressantsCNS Spectr20051073274716142213
   PubMed Web of Science ®Google Scholar
• YoshidaKTakahashiHHiguchiHPrediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphismsAm J Psychiatry20041611575158015337646
   PubMed Web of Science ®Google Scholar
• HindmarchIPsychomotor function and psychoactive drugsBr J Clin Pharmacol1980101892097002180
   PubMed Web of Science ®Google Scholar
• HindmarchIRigneyUStanleyNBrileyMPharmacodynamics of milnacipran in young and elderly volunteersBr J Clin Pharmacol20004911812510671905
   PubMed Web of Science ®Google Scholar
• SechterDVandelPWeillerEA comparative study of milnacipran and paroxetine in outpatients with major depressionJ Affect Disord20048323323615555719
   PubMed Web of Science ®Google Scholar
• PuechAMontgomerySAProstJFMilnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerabilityInt Clin Psychopharmacol199712991089219045
   PubMed Web of Science ®Google Scholar
• KasperSThe place of milnacipran in the treatment of depressionHum Psychopharmacol199712S135S141
   Web of Science ®Google Scholar
• FukuchiTKanemotoKDifferential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control studyInt Clin Psychopharmacol200217535811890186
   PubMed Web of Science ®Google Scholar
• LemoinePFaivreTSubjective and polysomnographic effects of milnacipran on sleep in depressed patientsHum Psychopharmacol20041929930315252822
   PubMed Web of Science ®Google Scholar
• BrileyMMoretCImprovement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitorsNeuropsychiatr Dis Treat2010664765520957125
   PubMed Web of Science ®Google Scholar
• UedaNYoshimuraRHoujoTEffects of milnacipran on social adaptation in patients with depressionRinshyo Seisin Yakuri200811273279
   Google Scholar
• IshidaTInadaYKudoMStudy on the clinical efficacy of milnacipran by using the Social Adaptation Self-evaluation ScaleJap J Clin Psychopharmacol2010137783
   Google Scholar